30Apr 2025
OnabotulinumtoxinA Dosing Key to Optimal Facial Line Treatment

OnabotulinumtoxinA Dosing Key to Optimal Facial Line Treatment

Maximizing benefit from onabotulinumtoxinA in upper facial lines requires appropriate dosing, according to a review of dosing science and clinical outcomes. Standard doses (~20–24 U per area) achieve a median effect duration of ~4 months. Underdosing leads to shorter efficacy and lower satisfaction without improving safety, while emerging data suggest higher-than-approved doses could enhance outcomes without added risks, particularly in the glabella.

  • #dermatology

Like

Save

Share